Vasodilator treatment for acute and chronic heart failure.

Abstract

The current status of the use of vasodilator drugs in the treatment of acute and chronic heart failure has been reviewed. It is apparent that vasodilator treatment can be used effectively in some patients with heart failure with a beneficial haemodynamics response, and that vasodilator agents are likely to find an important place in the management of such patients. Vasodilator treatment may be associated with complications and must be used with care. Though several nonparenteral vasodilator agents have been investigated, no ideal drug is yet available for the treatment of chronic heart failure. Nevertheless, it is probable that suitable drugs will emerge and find an important place in the management of such patients.

• Authors: K Chatterjee, W W Parmley
• Journal: British heart journal (Br Heart J) Vol. 39 Issue 7 Pg. 706-20 (Jul 1977) ISSN: 0007-0769 [Print] England
• PMID: 884021 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S.)

Chemical References

• Vasodilator Agents

Topics

• Aortic Valve Insufficiency (drug therapy)
• Heart Diseases (drug therapy)
• Heart Failure (drug therapy)
• Hemodynamics (drug effects)
• Humans
• Hypotension (chemically induced)
• Mitral Valve Insufficiency (drug therapy)
• Myocardial Infarction (drug therapy)
• Vascular Resistance (drug effects)
• Vasodilator Agents (adverse effects, pharmacology, therapeutic use)